Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists

Platform Signal Tracker API Radar Book a 7-day Readout

LB Pharmaceuticals, Inc.

Pioneering advancements in CNS treatment by bringing overseas innovations to the U.S. market through dedicated research and improved drug versions.

Founded 2015 1 employees Total: $538.14M Biopharma, Biotechnology +1

General Information

Company Name LB Pharmaceuticals, Inc.

Founded Year 2015

Founders / Decision Makers

Employees 1

Industries Biopharma, Biotechnology, Pharmaceutical

Social

BounceWatch is an independent company data service, not affiliated with LB Pharmaceuticals, Inc.. To contact LB Pharmaceuticals, Inc., visit lbpharma.us.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does LB Pharmaceuticals, Inc. compare?

A PDF of LB Pharmaceuticals, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting LB Pharmaceuticals, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

From the desk

Is LB Pharmaceuticals, Inc. on your competitive set?

Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.

Book a 7-day Readout

Discover More

Biopharma

Industry Signals All Companies

LB Pharmaceuticals, Inc. Alternatives

All Signals Trend Reports

About LB Pharmaceuticals, Inc.

LB Pharmaceuticals, Inc. is a pioneering life sciences company founded in 2015. The company focuses on revolutionizing CNS treatment by introducing innovative and improved versions of successful therapies from overseas to the U.S. market. Its mission is to develop and market therapies widely used abroad but not yet available in the United States. LB Pharmaceuticals creates a research-driven environment to generate new intellectual property related to these once-leading medications. The latest investment of $75.00M in Series C funding, led by Pontifax in 24 January 2024, demonstrates the growing interest and confidence from investors in the company's unique approach to CNS treatment. With a focus on biopharma, biotechnology, and pharmaceuticals, LB Pharmaceuticals is poised to make a significant impact on the U.S. healthcare market.

Business keywords: CNS treatment, life sciences, innovation, drug development, research-driven, intellectual property, commercialization, overseas innovations, drug versions, development stage, commercializing, US market, research-focused, pharmaceuticals, medication marketing

Funding Rounds & Investors (11)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Private Placement VC	$100.00M	9	Pivotal bioVenture Partners, Commodore Capital +7	01 Feb 2026
IPO	$285.00M	-		01 Sep 2025
Series C	$75.00M	-		01 Jan 2024
Convertible Note	$35.00M	-		01 Sep 2023
Late VC	$16.57M	1	Tarnagulla Ventures	01 Nov 2022
Convertible Note	$10.00M	-		01 Sep 2020
Series A	$8.40M	1	Rivopharm	01 Mar 2019
Early VC	$6.30M	-		01 Nov 2018
Early VC	$440.00K	-		01 Dec 2017
Seed	$460.00K	-		01 Apr 2017

View All 11 Funding Rounds

LB Pharmaceuticals, Inc. Alternatives & Competitors

View All Alternatives

LB Pharmaceuticals, Inc. vs

OnQuality Pharmaceuticals Ltd. China

developing innovative drugs and drug delivery systems that improve the quality of life of oncology p...

Series A

7 employees

Biopharma, Biotechnology

LB Pharmaceuticals, Inc. vs

Hua Medicine

Hua Medicine is a leading clinical-stage, innovative drug development company in China, focusing on...

Series E

56 employees

Biotechnology, Health Care

LB Pharmaceuticals, Inc. vs

Gordion Bioscience United States

MOTIVATED TO MAKE BETTER DRUGS - POWERED WITH TUMOR DATA - DELIVERED BY MACHINE LEARNING

7 employees

Biopharma, Biotechnology

View all alternatives

FAQ About LB Pharmaceuticals, Inc.

Pioneering advancements in CNS treatment by bringing overseas innovations to the U.S. market through dedicated research and improved drug versions.

LB Pharmaceuticals, Inc. was founded in 2015.

LB Pharmaceuticals, Inc. operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on CNS treatment, life sciences, innovation and drug development.

LB Pharmaceuticals, Inc. has approximately 1 employees.

LB Pharmaceuticals, Inc. has completed 11 funding rounds, raising a total of $538.14M.

Top alternatives and competitors to LB Pharmaceuticals, Inc. include OnQuality Pharmaceuticals Ltd., Hua Medicine, Gordion Bioscience, Yamo Pharmaceuticals, F-star Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

LB Pharmaceuticals, Inc. and OnQuality Pharmaceuticals Ltd. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for LB Pharmaceuticals, Inc., https://bouncewatch.com/company/lb-pharmaceuticals-inc, updated 10 June 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). We use analytics cookies (our own and Google Analytics) to understand how the site is used. Essential cookies are always on. You decide on analytics. Cookie Policy

Talk to an analyst Book a 7-day Readout